プレフィルドシリンジの市場規模、シェア、成長分析、タイプ別、材料別、用途別、流通チャネル別、地域別 - 産業予測 2025-2032年

プレフィルドシリンジ市場規模は2023年に83億米ドルと評価され、2024年の92億4,000万米ドルから2032年には217億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは11.3％で成長する見通しです。

プレフィルドシリンジは、便利なソリューションを求める製薬業界によって、単回投与薬の送達方法として急速に普及しています。世界保健機関（WHO）の2022年の調査結果では、避妊薬のような効果的なセルフケア介入によって、意図しない妊娠を大幅に減らすことができることが強調されており、ヘルスケアにおける自己管理の傾向が強まっていることが強調されています。セルフケアに費やす時間は年間8,700時間を超えるが、診察に費やす時間は1時間未満であることから、プレフィルドシリンジの需要は急増すると予測されます。さらに、糖尿病や関節炎の患者数の増加、先進国におけるバイオシミラーの存在感の高まりが、市場の成長をさらに後押しします。特に、関節炎は米国で年間1,400万人以上が罹患していると報告されており、プレフィルドシリンジは患者のセルフケアと安全性において重要な技術革新であると位置づけられています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 原材料の分析

プレフィルドシリンジ市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 使い捨て
• 再利用可能

プレフィルドシリンジ市場規模：材料別& CAGR（2025-2032）

• 市場概要
• ガラス
• プラスチック

プレフィルドシリンジ市場規模：用途別& CAGR（2025-2032）

• 市場概要
• ワクチンと予防接種
• アナフィラキシー
• 関節リウマチ
• 糖尿病
• 自己免疫疾患
• 腫瘍学
• その他

プレフィルドシリンジ市場規模：流通チャネル別& CAGR（2025-2032）

• 市場概要
• 病院
• 通信販売薬局
• 外来手術センター

プレフィルドシリンジ市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Becton, Dickinson and Company（BD）（USA）
• Gerresheimer AG（Germany）
• Schott AG（Germany）
• Baxter International Inc.（USA）
• Cardinal Health, Inc.（USA）
• Terumo Corporation（Japan）
• West Pharmaceutical Services, Inc.（USA）
• Nipro Corporation（Japan）
• Ompi（Italy）
• SGD Pharma（France）
• Stevanato Group（Italy）
• Medtronic plc（Ireland）
• Fresenius Kabi AG（Germany）
• Ypsomed Holding AG（Switzerland）
• ARaymondlife SAS（France）
• Credence MedSystems, Inc.（USA）
• Nemera（France）
• Taisei Kako Co., Ltd.（Japan）
• Weigao Group（China）
• Braun Melsungen AG（Germany）

結論と提言

Prefilled Syringes Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 9.24 billion in 2024 to USD 21.75 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

Pre-filled syringes are rapidly becoming a preferred delivery method for single-dose medications, driven by the pharmaceutical industry's quest for convenient solutions. The World Health Organization's 2022 findings highlight that effective self-care interventions, such as contraceptives, can significantly lower unintended pregnancies, emphasizing the growing trend towards self-management in healthcare. With individuals dedicating over 8,700 hours annually to self-care but less than an hour in consultations, the demand for pre-filled syringes is projected to surge. Additionally, rising cases of diabetes, arthritis, and the growing presence of biosimilars in developed nations further bolster market growth. Notably, a report indicated arthritis affects over 14 million annually in the U.S., positioning pre-filled syringes as a critical innovation in patient self-care and safety.

Top-down and bottom-up approaches were used to estimate and validate the size of the Prefilled Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Prefilled Syringes Market Segments Analysis

Global Prefilled Syringes Market is segmented by Type, Material, Application, Distribution Channel and region. Based on Type, the market is segmented into Disposable and Reusable. Based on Material, the market is segmented into Glass and Plastic. Based on Application, the market is segmented into Vaccines and immunizations, Anaphylaxis, Rheumatoid Arthritis, Diabetes, Autoimmune diseases, Oncology and Others. Based on Distribution Channel, the market is segmented into Hospitals, Mail Order Pharmacies and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Prefilled Syringes Market

The rising prevalence of chronic conditions, including diabetes mellitus and rheumatoid arthritis, has significantly boosted the demand for vaccines, which are primarily delivered through injections. This surge in vaccine administration has consequently heightened the need for prefilled syringes. These syringes offer controlled packaging that not only decreases the risk of contamination but also helps to minimize dosing errors, positioning them as the ideal option for both vaccines and therapeutics. Their strong application across various medical fields is driving growth in the prefilled syringes market, making them essential in addressing the increasing healthcare challenges associated with chronic illnesses.

Restraints in the Prefilled Syringes Market

The pre-filled syringes market faces several restraints primarily due to the stringent manufacturing processes involved. Unlike conventional syringes, pre-filled syringes require rigorous quality assurance protocols and strict compliance with regulatory standards to guarantee sterility, dosage accuracy, and overall patient safety. Furthermore, manufacturers are obligated to adhere to varying regulatory guidelines across different geographical regions, which can result in extended approval timelines and elevated production costs. These factors collectively pose significant challenges for companies in the pre-filled syringes market, potentially hindering their ability to efficiently produce and distribute these specialized medical devices.

Market Trends of the Prefilled Syringes Market

The prefilled syringes market is witnessing a notable shift towards polymer-based solutions, driven by the demand for enhanced safety and durability in drug delivery systems. Traditionally dominated by glass due to its inert properties, the market is increasingly adopting polymeric materials like cyclic olefin polymers (COP) and cyclic olefin copolymers (COCs). These innovative alternatives mitigate risks associated with glass breakage and contamination, making them particularly suitable for biologics and complex pharmaceuticals that require precise dosing. As pharmaceutical companies prioritize robust and user-friendly designs, the trend towards polymer-based prefilled syringes is anticipated to gain momentum, shaping the future landscape of drug administration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Raw Material Analysis

Global Prefilled Syringes Market Size by Type & CAGR (2025-2032)

• Market Overview
• Disposable
• Reusable

Global Prefilled Syringes Market Size by Material & CAGR (2025-2032)

• Market Overview
• Glass
• Plastic

Global Prefilled Syringes Market Size by Application & CAGR (2025-2032)

• Market Overview
• Vaccines and immunizations
• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Autoimmune diseases
• Oncology
• Others

Global Prefilled Syringes Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospitals
• Mail Order Pharmacies
• Ambulatory Surgery Centers

Global Prefilled Syringes Market Size & CAGR (2025-2032)

• North America (Type, Material, Application, Distribution Channel)
  • US
  • Canada
• Europe (Type, Material, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Material, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Material, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Material, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ompi (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGD Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARaymondlife SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Credence MedSystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemera (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taisei Kako Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weigao Group (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations